Shandra Eisenga Human Cell and Tissue Product Safety Act

Bill 119 hr 1082, also known as the Human Cell and Tissue Products Transplants Awareness Act, aims to address the lack of public and healthcare provider awareness regarding the potential risks and benefits of human cell and tissue products transplants. The bill requires the Secretary of Health and Human Services to conduct a national, evidence-based education campaign to increase awareness on this topic.

The campaign will focus on educating the public and healthcare providers about the risks and benefits associated with human cell and tissue products transplants. This includes information on the safety, efficacy, and potential complications of these procedures. By increasing awareness, the bill aims to ensure that individuals are well-informed when considering these types of transplants.

In addition to the education campaign, the bill also includes provisions for other purposes related to human cell and tissue products transplants. These may include regulations, guidelines, or funding for research and development in this field. Overall, Bill 119 hr 1082 seeks to improve public and healthcare provider awareness regarding human cell and tissue products transplants in order to promote informed decision-making and ensure the safety and efficacy of these procedures.